Immunovant (IMVT) Interest Coverage Ratio (QoQ) (2019 - 2026)
Immunovant (IMVT) Interest Coverage Ratio (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Immunovant | 7.18 Bn | 7.18 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -861,824.77% |
| Dec 31, 2025 | 104.28% |
| Sep 30, 2025 | -160.30% |
| Jun 30, 2025 | -220.44% |
| Mar 31, 2025 | 35.93% |
| Dec 31, 2024 | -29.18% |
| Sep 30, 2024 | -10.39% |
| Jun 30, 2024 | 102.81% |
| Mar 31, 2024 | -2,523.53% |
| Dec 31, 2023 | 3.39% |
| Sep 30, 2023 | 89.45% |
| Jun 30, 2023 | 101.57% |
| Mar 31, 2023 | -6,431.85% |
| Dec 31, 2022 | 102.31% |
| Sep 30, 2022 | 99.37% |
| Jun 30, 2022 | -1,335.10% |
| Mar 31, 2022 | -783.75% |
| Dec 31, 2021 | -58.67% |
| Sep 30, 2021 | -456.61% |
| Dec 31, 2020 | -7,719.06% |